| ARCT latest price $26.3200 (-2.84%) ($25.4800 - $27.3000) on Tue. Dec. 23, 2014. |
|
|
| Trend Analysis and Forecast |
| |
Average Daily Percentage Swing | 9.58% (three month average) |
RSI | 62 |
Latest Price | $26.3200(-2.84%) |
Stocks Behave Similarly | Similar Stock List |
Daily Trend | ARCT advances 1% a day on average for past five trading days. |
Weekly Trend | ARCT advances 11.9% a week on average for past two weeks. |
Market Behavior | Value stock rally for large cap. Normal for small cap. |
Correlated ETFs | Broad market will support ARCT advance at 0% a week (0% probability) IBB(6%) XBI(6%) XLV(5%) IWM(3%) XHB(3%) |
Factors Impacting ARCT price | ARCT will decline at least -4.79% in a week (0% probabilities). LQD(-5%) VIXM(-4%) CEMB(-3%) BND(-3%) XLU(-2%) |
Explanation | The rally is not sustainable and not supported by the broad market. |
| |
| |
Relative Volatility | (options are extremely cheap) |
| |
Market Trend Strength | -4.79% (StdDev 9.58%) |
Hourly BBV | 0 () |
Intraday Trend | -3.6% |
| |
|
|
July 7, 2020 ARCT develops mRNA based covid vaccine. Now it's still in preclinical stage, and plan to start phase I clinic trail this summer.